Basic Information
| LncRNA/CircRNA Name | circ_0076251 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | liver cancer |
| ICD-0-3 | C22.0 |
| Methods | qPCR |
| Sample | liver cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | Our data demonstrated that the hsa_circ_0028502 and hsa_circ_0076251 levels were considerably lower in HCC tissues than in adjacent paracancerous tissues (P < .001). Further study revealed that hsa_circ_0028502 expression levels were related to tumor node metastasis (TNM) stage (P = .015) and that hsa_circ_0076251 expression levels were related to Barcelona Clinic Liver Cancer (BCLC) stage (P = .038). |
| Pubmed ID | 31595711 |
| Year | 2019 |
| Title | Hsa_circ_0028502 and hsa_circ_0076251 Are Potential Novel Biomarkers for Hepatocellular Carcinoma |
External Links
| Links for circ_0076251 | GenBank HGNC NONCODE |
| Links for liver cancer | OMIM COSMIC |